单极性抑郁症胺:对疗效和安全性的系统性审查
Tharshanan Edwin Peiris1, Amrit Pokhrel2, Yuvaraj Paudel3
1Department of Psychiatry, The Royal Australian and New Zealand College of Psychiatrists, Melbourne, VIC, Australia.
概括
胺可以快速缓解治疗耐药单极性抑郁症,在几个小时内显著减少症状和自杀念头. 需要进一步的研究来确认这种快速起作用的抗抑郁药的长期安全性和最佳使用.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 单极性抑郁症是一种广泛的心理健康状况,具有持久的,难以治疗的症状.
- 目前的抗抑郁药需要数周才能变得有效,这凸显了需要快速起作用的替代品的需要.
- 胺,一种麻醉剂,正在显示出作为快速起作用的抗抑郁药的潜力.
研究的目的:
- 系统地审查胺胺在治疗单极性抑郁症方面的疗效和安全性.
- 分析胺在减少抑郁症状和自杀念头方面的有效性.
- 评估与胺治疗相关的不良事件.
主要方法:
- 从2000年1月到2024年5月,在PubMed,PsycINFO和Cochrane图书馆进行了全面的文献搜索.
- 包括的研究包括RCT,CCT,系统审查,元分析和涉及胺或胺的观察性研究.
- 对研究特征,干预措施,结果和不良事件的数据进行了系统分析,并进行了质量和偏差评估.
主要成果:
- 在44项研究中,胺在几个小时内显著减少了抑郁症状和自杀念头.
- 这些快速的抗抑郁药效应在耐治疗抑郁症患者中尤为明显,持续时间长达一周.
- 常见的副作用包括暂时分离,血压升高,恶心和头;长期的安全性仍未确定.
结论:
- 胺为治疗耐药单极性抑郁症的快速抗抑郁药物治疗提供了一个有前途的选择.
- 进一步的研究对于建立长期安全概况和定义最佳治疗方案至关重要.
- 胺的临床实施应涉及仔细监测和整合到现有的治疗模式.
更多相关视频
10:23Equipment Setup and Artifact Removal for Simultaneous Electroencephalogram and Functional Magnetic Resonance Imaging for Clinical Review in Epilepsy
Published on: June 23, 2023
1.8K
08:36Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
396
相关概念视频
01:30Electroconvulsive Therapy
18
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
18
01:23Antidepressant Drugs: MAOIs and Other Agents
164
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
164
01:18Depression: Overview
197
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
197
01:23Sedatives and Hypnotics: Overview
236
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
236
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
129
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
129